Camptocormia in Parkinson's disease
Kazuo Abe1, Yutaka Uchida, Masaru Notani
1Department of Nursing and Rehabilitation, Konan Women's University, Kobe 657-0001, Japan.
Parkinson'S Disease
|October 16, 2010
Summary
Camptocormia, or bent spine, is more common in Parkinson's disease (PD) than previously thought. This condition significantly impacts quality of life, suggesting targeted treatments could improve patient well-being.
Area of Science:
- Neurology
- Movement Disorders
- Parkinson's Disease Research
Background:
- Postural abnormalities are characteristic of Parkinson's disease (PD).
- Camptocormia, a severe forward-bending posture, has been historically underestimated in PD prevalence.
- Understanding camptocormia's frequency and impact is crucial for comprehensive PD management.
Purpose of the Study:
- To determine the actual frequency of camptocormia in Parkinson's disease patients.
- To investigate the clinical and non-motor features associated with camptocormia in PD.
- To assess the impact of camptocormia on the quality of life for individuals with Parkinson's disease.
Main Methods:
- A cohort of 153 Parkinson's disease patients underwent neurological examination and standardized assessments (UPDRS Part III, MMSE).
- Patients with and without camptocormia were compared, with further evaluation including MRI, EMG, and specific questionnaires (FAB, PDQ-8, FSQ, VAS-F, NMSS).
- Age- and sex-matched controls were used for robust comparative analysis.
Main Results:
- Camptocormia was identified in 27 out of 153 Parkinson's disease patients, indicating a higher prevalence than previously assumed.
- No significant differences were found in age, disease duration, motor severity, or medication dosage between groups.
- Patients with camptocormia exhibited notable differences in non-motor symptoms, including sleep/fatigue, attention/memory, and miscellaneous items, and reported lower quality of life scores (PDQ-8).
Conclusions:
- Camptocormia is a relatively common and significant postural abnormality in Parkinson's disease.
- The presence of camptocormia is associated with specific non-motor symptoms and a reduced quality of life in PD patients.
- Addressing camptocormia may offer a pathway to improving the overall well-being and quality of life for individuals with Parkinson's disease.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:15REM Sleep Behavior Disorder
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...